Hiroyuki Oshikiri

4PUBLICATIONS
6CO-AUTHORS
Molecular targetsPacific Peoples life courseMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 24, 2024
Anticancer Effect of C19-Position Substituted Geldanamycin Derivatives Targeting NRF2-NQO1-activated Esophageal Squamous Cell Carcinoma.

Hiroyuki Oshikiri, Keiko Taguchi, Wataru Hirose

|Oct 14, 2022
The KEAP1-NRF2 System and Esophageal Cancer.

Wataru Hirose, Hiroyuki Oshikiri, Keiko Taguchi

|Mar 16, 2022
Benign multicystic peritoneal mesothelioma occurring in bilateral inguinal canals metachronously: a case report.

Hiroyuki Oshikiri, Yohei Ozawa, On Suzuki

Pageof 1